Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its association with early progression of glycaemic deterioration in persons without diabetes has not been fully investigated. Our primary aim was to assess longitudinal associations of changes in pro-inflammatory (leukocytes, high-sensitivity C-reactive protein (hsCRP)) and anti-inflammatory (adiponectin) markers with changes in markers that assessed glycaemia, insulin resistance, and secretion (HbA(1c), HOMA-IR, and HOMA-beta). Furthermore, we aimed to directly compare longitudinal with cross-sectional associations. Materials and methods Results This study includes 819 initially nondiabetic individuals with repeated measurements from the Coope...
Objective: Higher systemic levels of pro-inflammatory biomarkers and low adiponectin are associated ...
PURPOSE: Subclinical systemic inflammation may lead to development of type 2 diabetes, but there has...
Background: Insulin resistance (IR) can contribute to the development of type 2 diabetes. Asymptomat...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims: Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but it...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims: Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but it...
Aims: Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but it...
Aims/hypothesis The role of biomarkers of subclinical inflammation in the early deterioration of gly...
Aims/hypothesis: The role of biomarkers of subclinical inflammation in the early deterioration of gl...
Objective: Higher systemic levels of proinflammatory biomarkers and low adiponectin are associated w...
Abstract Context: Low-grade inflammation is involved in the development of type 2 diabetes and card...
Objective: Higher systemic levels of pro-inflammatory biomarkers and low adiponectin are associated ...
PURPOSE: Subclinical systemic inflammation may lead to development of type 2 diabetes, but there has...
Background: Insulin resistance (IR) can contribute to the development of type 2 diabetes. Asymptomat...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims: Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but it...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but its...
Aims: Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but it...
Aims: Subclinical systemic inflammation may contribute to the development of type 2 diabetes, but it...
Aims/hypothesis The role of biomarkers of subclinical inflammation in the early deterioration of gly...
Aims/hypothesis: The role of biomarkers of subclinical inflammation in the early deterioration of gl...
Objective: Higher systemic levels of proinflammatory biomarkers and low adiponectin are associated w...
Abstract Context: Low-grade inflammation is involved in the development of type 2 diabetes and card...
Objective: Higher systemic levels of pro-inflammatory biomarkers and low adiponectin are associated ...
PURPOSE: Subclinical systemic inflammation may lead to development of type 2 diabetes, but there has...
Background: Insulin resistance (IR) can contribute to the development of type 2 diabetes. Asymptomat...